13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001832108
Total reported value
$8.6M
$8.6M
2 檔
218.4%
According to the latest 13F quarterly dataset, ABG-WTT Global Life Science Capital Partners GP Ltd managed an equity portfolio of $8.6M at the end of Q3 2025, spanning 2 distinct U.S. exchange-listed positions.
In Q3 2025, ABG-WTT Global Life Science Capital Partners GP Ltd adopted a defensive or profit-taking posture, trimming 0 positions and completely liquidating 2 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including CBLL, RPID) accounted for 218.4% of total reported equity market value during Q3 2025.
Top Position Liquidated / Trimmed
CGON
前期市值: $12.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CBLL | Ceribell Inc | Stock-Other | 66.94% | -3.26% | — | |
| 2 | RPID | Rapid Micro Biosystems Inc-a | Stock-Other | 33.06% | +3.26% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RPID | Rapid Micro Biosystems Inc-a | +20.3% | — | Unchanged |
| 2 | CBLL | Ceribell Inc | +12.4% | — | Unchanged |
| 3 | CGON | Cg Oncology Inc | — | EXIT | Sold out |
| 4 | LUNG | Pulmonx CORP | — | EXIT | Sold out |
According to official SEC Form 13F filings, ABG-WTT Global Life Science Capital Partners GP Ltd reported a total U.S. public equity portfolio value of $8.6M across 2 disclosed positions in Q3 2025.
During Q3 2025, ABG-WTT Global Life Science Capital Partners GP Ltd's top holdings by market value included CBLL (66.9%)、RPID (33.1%). The largest single position, CBLL, represented 66.9% of total portfolio value.
In Q3 2025, ABG-WTT Global Life Science Capital Partners GP Ltd made 2 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.